Original Investigation

The Efficacy and Safety of Probing as a Treatment Procedure for Congenital Nasolacrimal Duct Obstruction

10.5152/imj.2013.51

  • Tolga Yılmaz
  • Ahu Yılmaz
  • Ahmet Kırgız
  • Muhittin Taşkapılı

Received Date: 03.07.2012 Accepted Date: 27.08.2012 İstanbul Med J 2013;14(3):191-194

Objective:

To evaluate the efficacy and safety of Probing as a treatment procedure for congenital nasolacrimal duct obstruction.

Methods:

In this study, 55 eyes of 45 patients who underwent probing for congenital nasolacrimal duct obstruction were retrospectively reviewed. The patients were divided into three groups based on the timing of the procedure as Group 1 (11-17 months), Group 2 (18-24 months) and Group 3 (25-36 months). Postoperative follow up, safety and efficacy were evaluated.

Results:

The mean age of 25 female and 20 male patients was 19.3 months (11-36 month). Mean follow up was 11,8 months (6-18 months). The success was 88.4% (23 of 26 eyes) in Group 1, 70.5% (12 eyes of 17 eyes) in Group 2, and 41.7% (5 of 12 eyes) in Group 3. No complications were noted during follow-up.

Conclusion:

Probing procedure appears to be an effective and safety procedure for congenital nasolacrimal duct obstruciton in the early age group.

Keywords: Congenital nasolacrimal duct obstruction, probing, age